Moreover, since resistance to antiangiogenic treatments also relies on the occurrence of VM [53], the activation of the IL-3/IL-3Rα-mediated signalling may represent one of the rescue pathways granting tumour cell survival in this clinical scenario. This evidence concerns the gene IL3RA and neoplasm.